Research theme for competitive and other funds (6)：
2024 - 2027 休眠結核菌のin vivo再活性化実験系の開発
2023 - 2026 Protective immune responses against non-tuberculous mycobacteria in a murine pulmonary infection model
2021 - 2024 分裂のON/OFFの可視化で明らかにする休眠結核菌の再活性化機構
2020 - 2023 Expanding functional genomics of nontuberculous mycobacteria for establishing strategies for prevention, predictive diagnosis and drug development
2019 - 2022 Study on biological factors for prediction of disease risk and shorter treatment of tuberculosis
2016 - 2017 The mechanisms underlying the VBNC state of Salmonella
Show all
Papers (28)：
T. Kodama, K. Chikamatsu, K. Kamada, K. Mizuno, Y. Morishige, Y. Igarashi, A. Osugi, A. Aono, Y. Murase, M. Okumura, et al. Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB. The International Journal of Tuberculosis and Lung Disease. 2024. 28. 10. 476-481
Linfeng Wang, Dodge R Lim, Jody E Phelan, Lorenzo T Reyes, Alma G Palparan, Maria Guileane C Sanchez, Louella Abigail A Asuncion, Ma Angelica A Tujan, Inez Andrea P Medado, Chona Mae A Daga, et al. Whole genome sequencing analysis of Mycobacterium tuberculosis reveals circulating strain types and drug-resistance mutations in the Philippines. Scientific reports. 2024. 14. 1. 19602-19602
Fumiya Watanabe, Yasuhiko Matsumoto, Takashi Sugita, Yuta Morishige, Satoshi Mitarai, Yoshihiko Hoshino, Kazuhiko Hanada. Pharmacokinetics of anti-Mycobacterium avium-intracellulare disease drugs in silkworms. Scientific reports. 2024. 14. 1. 16931-16931
Izumi Yamatani, Akio Aono, Keiji Fujiwara, Takahiro Asami, Keisuke Kamada, Yuta Morishige, Yuriko Igarashi, Kinuyo Chikamatsu, Yoshiro Murase, Hiroyuki Yamada, et al. In vitro effects of the new oral β-lactamase inhibitor xeruborbactam in combination with oral β-lactams against clinical Mycobacterium abscessus isolates. Microbiology spectrum. 2024. e0008424
Kosaku Komiya, Mitsunori Yoshida, Sonoe Uchida, Shuichi Takikawa, Mari Yamasue, Takashi Matsumoto, Yuta Morishige, Akio Aono, Kazufumi Hiramatsu, Yoshio Yamaoka, et al. Massive and Lengthy Clonal Nosocomial Expansion of Mycobacterium abscessus subsp. massiliense among Patients Who Are Ventilator Dependent without Cystic Fibrosis. Microbiology spectrum. 2023. 11. 4. e0490822
血清アルブミンによるVBNC(viable but non-culturable)結核菌の再活性化機構の解析
(第7回抗酸菌研究会 2023)
Induction of dormancy of Mycobacterium abscessus species via hypoxic stress
(The 79th Annual Meeting of The Japanese Society of Microscopy 2023)
Reactivation effects of serum albumin to viable but non-culturable Mycobacterium tuberculosis
(The 96th Annual Meeting of Japanese Society for Bacteriology 2023)
Reactivation effects of albumin and antioxidative agents to viable but non-culturable Mycobacterium tuberculosis - a wake-up call for tubercle bacilli
(ASM Conference on Biofilms 2022 2022)
2012 - 2015 Graduate School of Osaka University of Pharmaceutical Sciences
2010 - 2012 Graduate School of Osaka University of Pharmaceutical Sciences
2006 - 2010 Osaka University of Pharmaceutical Sciences School of Pharmacy
Professional career (1)：
PhD
Work history (2)：
2017/04 - 現在 Japan Anti-Tuberculosis Association Department of Mycobacterium Reference & Research
2015/04 - 2017/03 Osaka University of Pharmaceutical Sciences School of Pharmacy Postdoctoral fellow
Committee career (3)：
2023/04 - 現在 日本薬学会 ファルマシアトピックス小委員会委員
2023 - 現在 抗酸菌研究会 運営委員
2017/08 - 現在 日本バイオフィルム学会 広報委員会委員
Awards (4)：
2021/08 - 日本バイオフィルム学会第35回学術集会 若手優秀発表賞
2017/08 - 29th Symposium on Microbial Science, The Pharmaceutical Society of Japan Best Abstract Award
2015/12 - BMB2015 Biochemistry and Molecular Biology Young Scientists Excellent Presentation Award
2014/07 - International Union of Microbiological Societies Congress 2014 Travel Support
Association Membership(s) (6)：
American Society for Microbiology
, THE JAPANESE SOCIETY FOR TUBERCULOSIS
, THE JAPANESE SOCIETY FOR BIOFILM RESEARCH
, JAPANESE SOCIETY FOR BACTERIOLOGY
, 日本顕微鏡学会
, THE JAPANESE SOCIETY FOR CLINICAL MICROBIOLOGY
